Pitfalls in non-therapeutic research in children

Related Experiment Video

Updated: Jul 19, 2026

An Experimental Analysis of Children's Ability to Provide a False Report about a Crime
07:36

An Experimental Analysis of Children's Ability to Provide a False Report about a Crime

Published on: May 3, 2016

George B Mallory1

  • 1Department of Pediatrics, Baylor College of Medicine, Texas Children's Hospital, Houston, Texas 77030, USA. gbmallor@texaschildrenshospital.org

Pediatric Pulmonology
|September 26, 2006
PubMed

Insights

This study examines the ethical considerations of including children in non-therapeutic research. It finds that the research design in question may not meet federal regulatory standards for protecting child participants.

Area of Science:

  • Pediatric research ethics
  • Regulatory compliance in human subjects research

Background:

  • Medical advances benefit all, but children require special protections in research.
  • Non-therapeutic research involving minors presents ethical challenges regarding potential harm and exploitation.
  • Institutional review boards and caregivers play crucial roles in safeguarding child participants.

Purpose of the Study:

  • To systematically analyze a specific research study's design.
  • To evaluate the study's adherence to the United States Code of Federal Regulations.
  • To assess the ethical implications of pediatric non-therapeutic research.

Main Methods:

  • Analysis of a research study's design.
  • Application of methodology from the United States Code of Federal Regulations.
  • Systematic review of ethical considerations for child research participants.

Main Results:

  • The analyzed research design appears to fall short of federal regulatory requirements.
  • Concerns identified regarding the protection of children in non-therapeutic research.
  • Potential ethical and regulatory non-compliance noted.

Conclusions:

  • Children require stringent protections in research, especially non-therapeutic studies.
  • The analyzed study's design may not adequately safeguard pediatric participants.
  • Adherence to federal regulations is paramount in pediatric research ethics.

More Related Videos

Eye Tracking Young Children with Autism09:03

Eye Tracking Young Children with Autism

Published on: March 27, 2012

Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure15:18

Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure

Published on: July 30, 2009

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Ethics in Research01:56

Ethics in Research

Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...